CHEOY:OTCMKTS
Cochlear Ord ADR
44,70Â USD
arrow_downward
−0,10%(−0,045) 1 D
15. okt., 11:10:38 GMT-4 · USD
search
Alle symboler
| Symbol | Pris | Endring | Endring (%) |
|---|
insights_autoGenererer viktig statistikk for CHEOY …
Ã…pne
44,61Â USD
Høy
44,70Â USD
Lav
44,61Â USD
Markedsverdi
8,42Â mrd.
Snittvolum
18,50k
Volum
4,84k
52 u høy
98,49Â USD
52Â u lav
31,82Â USD
Beta
0,68
Utestående aksjer
130,80Â mill.
Antall ansatte
5k
Ã…pne
44,61Â USD
Høy
44,70Â USD
Lav
44,61Â USD
Markedsverdi
8,42Â mrd.
Snittvolum
18,50k
Volum
4,84k
52 u høy
98,49Â USD
52Â u lav
31,82Â USD
Beta
0,68
Utestående aksjer
130,80Â mill.
Antall ansatte
5k
Nyhetssaker
Fra nettkilder og nyhetspartnere
Stocks Down Under
·
for 17 timer siden
Cochlear (ASX:COH) Share Price, Forecast & Analysis
PR Newswire
·
for 1 døgn siden
Cochlear Named #1 Most Trustworthy Healthcare Company In The World For 2026
Kalkine
·
for 2 døgn siden
Cochlear Limited (ASX:COH) Puts Global Market Share Defense & Sound Processor Innovation in Focus
Profil
Cochlear is a medical device company that designs, manufactures, and supplies the Nucleus cochlear implant, the Hybrid electro-acoustic implant and the Baha bone conduction implant.
Based in Sydney, Cochlear was formed in 1981 as a subsidiary of Nucleus with finance from the Australian government to commercialise the implants pioneered by Dr. Graeme Clark, although the company later became separate. As of 2022, the company holds 50% of the cochlear implant market, with more than 250,000 people receiving one of Cochlear's implants as of 2015.
Cochlear was named Australia's most innovative company by the Intellectual Property Research Institute of Australia in 2002 and 2003, and one of the world's most innovative companies by Forbes in 2011. Wikipedia
Om Cochlear Ord ADR
Administrerende direktørDig Howitt
Ansatte5,4k
Grunnlagt1981
HovedkontorSydney, New South Wales, Australia
Sektor-
Nettstedcochlear.com